Please assess the completion status of the following clinical trial:

Trial Title: Lyrica Dose Response Study With Restless Legs Syndrome (RLS) Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 6.0

Eligibility Criteria:
Inclusion Criteria:~* Moderate to severe idiopathic RLS~* symptoms occur predominantly in the evening~* symptoms interfere with sleep onset or maintenance~Exclusion Criteria:~* Any secondary RLS~* require treatment for daytime RLS symptoms~* symptomatic neuropathies

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: PLACEBO_COMPARATOR): Placebo
- 2 (Type: EXPERIMENTAL): investigational treatment
- 3 (Type: EXPERIMENTAL): investigational treatment
- 4 (Type: EXPERIMENTAL): investigational treatment
- 5 (Type: EXPERIMENTAL): investigational treatment
- 6 (Type: EXPERIMENTAL): investigational treatment

Based on this trial design, predict the completion outcome and termination type (if applicable).